Chronic infection of the lung is the No. 1 cause of death in cystic fibrosis patients. In this video, Gregory Omlor, MD, director of pulmonary medicine at Akron Children’s Hospital, discusses a study being conducted by his staff that compares the relative effectiveness of 2 delivery systems for Tobramycin, an antibiotic that helps prevent lung infections in cystic fibrosis patients.
Philanthropic contributions often mean the difference between good programs and exceptional programs. To fuel that philanthropic spirit, the Akron Children’s Hospital Foundation formed Physicians for Philanthropy, which encourages physicians’ involvement in fundraising, both personally and by working with families who are interested in giving.
At the most recent Medical Staff Executive Committee meeting, we approved and posted the Authorization for division directors or department chairs to sign a Standard Care Arrangement for an advanced practice provider as the designated representative.
Akron Children’s Hospital added new medical staff members for genetics, emergency medicine, advanced practice, neurology, pediatrics and maternal fetal medicine.